🇺🇸 FDA
Patent

US 11559565

Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides

granted A61KA61K38/12A61K38/18

Quick answer

US patent 11559565 (Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/12, A61K38/18, A61K38/1808, A61K38/1816